Idiopathic pulmonary fibrosis trials in France

In France 17 Also abroad 111

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Angers, Brest, Bron, Lille, Montpellier, Nice, Paris Cedex 18, Rennes, Tours
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Amiens Cedex 1, Angers, Bobigny, Bron, Lille Cedex, Marseille, Nice, Rennes Cedex 9, Saint-Herblain
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Angers, Montrevel-en-Bresse
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 2Not yet taking people in France
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Where
Angers, Bobigny, Bron, Caen, Grenoble Cedex 9, Le Kremlin Bicetre Cedex, Lille, Marseille, Paris Cedex 18, Pessac, Rennes, Saint-Herblain, Suresnes, Toulouse, Tours Cedex 9
Age
18 years and over
People
112 worldwide
Run by
Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 · EU 2026-526404-71-00
Phase 3Not yet taking people in France
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Angers, Bobigny, Brest, Bron, Dijon, Grenoble Cedex 9, Marseille, Nice, Paris Cedex 18, Pessac, Saint-Herblain, Toulouse
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Angers, Brest, Bron, Montpellier, Nice, Paris, Rennes, Tours
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Angers, Bobigny, Bron, Caen Cedex 9, Dijon, Grenoble Cedex 9, Lille, Marseille, Nice, Paris, Paris Cedex 18, Pessac, Reims Cedex, Rennes, Saint-Herblain, Suresnes
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Amiens, Bobigny, Bron, Caen, Marseille, Paris, Reims, Rennes, Rouen, Toulouse, Tours
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Amiens Cedex 1, Bobigny, Bron, Caen Cedex 9, Créteil, Marseille, Paris, Paris Cedex 18, Reims Cedex, Suresnes, Tours Cedex 9
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
Where
Angers, Bron, Montpellier Cedex 5, Tours
Age
18 years and over
People
128 worldwide
Run by
Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 · EU 2024-518289-28-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Angers, Bobigny Cedex, Brest Cedex 2, Bron, Dijon, Grenoble Cedex 9, Marseille, Paris Cedex 18, Pessac, Saint-Herblain, Toulouse, Tours
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Angers, Bobigny Cedex, Brest, Bron, Dijon, Grenoble Cedex 9, Marseille, Nice, Paris Cedex 18, Pessac, Saint-Herblain, Toulouse, Tours
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Amiens Cedex 1, Bobigny, Bron, Marseille, Montpellier, Paris Cedex 18, Pessac, Rennes Cedex 9, Tours
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
No phaseTaking people
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Where
Paris, Rennes
Age
18 years to 80 years
People
500 worldwide
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06855329
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Bobigny Cedex, Bron, Caen, Marseille, Rouen, Tours
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00
Phase 3Taking people
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Where
Angers, Besancon Cedex, Bobigny, Bron, Caen Cedex 9, Clermont Ferrand Cedex 1, Créteil, Dijon, Grenoble Cedex 9, Le Kremlin-Bicetre, Lille, Marseille, Montpellier Cedex 5, Nancy, Nice, Paris, Paris Cedex 14, Paris Cedex 18, Paris Cedex 20, Pessac, Reims, Rennes, Rouen Cedex, Saint-Herblain, Strasbourg Cedex, Suresnes, Toulouse Cedex 9, Tours
Age
18 years and over
People
110
Run by
Fondation Hôpital Saint-Joseph
See details and how to joinNCT05674994 · EU 2024-514799-42-00
No phaseTaking people
Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Where
Paris
People
3,000
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT06036719